The association between xylazine and DI may be linked to its pharmacologic effects as an alpha-2 adrenergic agonist, potentially exacerbating striatal dopamine transporter dysfunction, which is implicated in delusional parasitosis [14]. This evidence concerns the gene SLC6A3 and parasitic infectious disease.